The blood glucose monitoring systems market size has grown strongly in recent years. It will grow from $17.66 billion in 2025 to $19 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rise in global diabetes prevalence, increasing awareness of glucose self-monitoring, early commercialization of invasive glucose meters and test strips, expansion of home healthcare and outpatient diabetes care, growing emphasis on glycemic control to reduce complications.
The blood glucose monitoring systems market size is expected to see strong growth in the next few years. It will grow to $24.68 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for continuous glucose monitoring and flash monitoring systems, increasing adoption of wearable and implantable monitoring devices, higher uptake of remote and connected diabetes management solutions, growing penetration of non-invasive glucose sensing technologies, expanding use of monitoring systems in type 2, type 1, and gestational diabetes care. Major trends in the forecast period include increasing adoption of continuous and real-time blood glucose monitoring solutions, rising shift toward minimally invasive and non-invasive glucose monitoring technologies, growing use of portable, home-based, and self-monitoring glucose devices, expansion of blood glucose monitoring in preventive and chronic disease management, focus on enhancing accuracy, convenience, and patient control in diabetes care.
The growing prevalence of diabetes is expected to drive the expansion of the blood glucose monitoring systems market in the coming years. The increase in diabetes cases can be attributed to factors such as sedentary lifestyles, poor dietary habits, aging populations, and genetic predisposition. Blood glucose monitoring systems are essential for tracking and managing blood sugar levels, supporting disease control, and preventing complications. For example, in December 2023, the Australian Bureau of Statistics, a government agency based in Australia, reported that in 2022, 5.3% of Australians, or around 1.3 million people, were diagnosed with diabetes, with similar rates between males (5.8%) and females (4.9%). The prevalence of diabetes has been steadily rising, particularly with age, reaching 18.7% among individuals aged 75 and older. Type 2 diabetes, which accounts for 87.6% of cases, is the most common form. Factors such as being born overseas, living in disadvantaged areas, and having a disability are linked to higher diabetes rates. As a result, the increasing prevalence of diabetes is expected to drive the growth of the blood glucose monitoring systems market.
Leading companies in the glucose monitoring systems market are focused on advancing technologies such as hybrid closed-loop systems and smartphone applications for real-time data access and management. Hybrid closed-loop systems automate insulin delivery based on real-time glucose readings, enhancing blood sugar control for individuals with diabetes. For instance, in February 2024, DexCom Inc., a US-based manufacturer, introduced Dexcom ONE+ in multiple European countries. This system integrates advanced sensor technology and user-friendly features, including a water-resistant sensor, a transmitter for continuous glucose monitoring, and a smartphone-compatible app. Dexcom ONE+ allows real-time monitoring of blood glucose levels by users and up to ten additional individuals, facilitating shared monitoring.
In September 2023, Abbott Laboratories expanded its diabetes management portfolio by acquiring Bigfoot Biomedical Inc., a US-based company specializing in diabetes management technology. This strategic move strengthens Abbott’s capabilities in glucose monitoring and insulin management solutions for diabetic patients.
Major companies operating in the blood glucose monitoring systems market are F. Hoffmann-La Roche Ltd., Medtronic plc, Dexcom Inc., SD Biosensor Co. Ltd., Arkray Inc., Abbott Laboratories, Ypsomed Holding AG, LifeScan IP Holdings LLC, Ascensia Diabetes Care Holdings AG, TaiDoc Technology Corporation, Nemaura Medical Inc., Bionime GmbH, Acon Laboratories Inc., Rossmax International Ltd, AgaMatrix Inc., A. Menarini Diagnostics S.r.l., Medisana GmbH, Intuity Medical Inc., GlucoTrack Ltd., Sinocare Inc., Omron Healthcare Co Ltd, Trividia Health Inc.
North America was the largest region in the blood glucose monitoring systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood glucose monitoring systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood glucose monitoring systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the blood glucose monitoring systems market by increasing the cost of electronic sensors, semiconductor chips, batteries, plastics, and sterile consumables sourced through global supply chains, leading to higher device manufacturing and distribution costs. The impact is most visible in continuous glucose monitoring systems, self-monitoring blood glucose meters, and disposable test strip segments produced in Asia-Pacific and European manufacturing hubs dependent on imported raw materials and precision components. Retail and institutional buyers are experiencing price pressures and extended procurement cycles as tariff-related costs cascade through distributors and healthcare providers. Nonetheless, tariffs are also encouraging localized component sourcing, regional device assembly, and domestic innovation activities, which may strengthen supply resilience and support long-term market competitiveness.
The blood glucose monitoring systems market research report is one of a series of new reports that provides blood glucose monitoring systems market statistics, including blood glucose monitoring systems industry global market size, regional shares, competitors with a blood glucose monitoring systems market share, detailed blood glucose monitoring systems market segments, market trends and opportunities, and any further data you may need to thrive in the blood glucose monitoring systems industry. This blood glucose monitoring systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A blood glucose monitoring system is a medical device designed to measure and show the concentration of glucose in the blood. It typically includes a compact, portable meter and a test strip where a drop of blood from a fingertip is applied. This system plays a crucial role in diabetes management by enabling individuals to monitor and regulate their blood sugar levels.
There are two main types of blood glucose monitoring systems non-invasive and invasive. Non-invasive systems do not require drawing blood and include devices such as continuous glucose monitoring systems and self-monitoring blood glucose systems for fingertip and alternative site testing. These systems are sold through institutional and retail channels, serving applications in type 2 diabetes, type 1 diabetes, and gestational diabetes.
The blood glucose monitoring systems market consists of sales of blood glucose meters, test strips, lancets, and lancing devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The blood glucose monitoring systems market size is expected to see strong growth in the next few years. It will grow to $24.68 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for continuous glucose monitoring and flash monitoring systems, increasing adoption of wearable and implantable monitoring devices, higher uptake of remote and connected diabetes management solutions, growing penetration of non-invasive glucose sensing technologies, expanding use of monitoring systems in type 2, type 1, and gestational diabetes care. Major trends in the forecast period include increasing adoption of continuous and real-time blood glucose monitoring solutions, rising shift toward minimally invasive and non-invasive glucose monitoring technologies, growing use of portable, home-based, and self-monitoring glucose devices, expansion of blood glucose monitoring in preventive and chronic disease management, focus on enhancing accuracy, convenience, and patient control in diabetes care.
The growing prevalence of diabetes is expected to drive the expansion of the blood glucose monitoring systems market in the coming years. The increase in diabetes cases can be attributed to factors such as sedentary lifestyles, poor dietary habits, aging populations, and genetic predisposition. Blood glucose monitoring systems are essential for tracking and managing blood sugar levels, supporting disease control, and preventing complications. For example, in December 2023, the Australian Bureau of Statistics, a government agency based in Australia, reported that in 2022, 5.3% of Australians, or around 1.3 million people, were diagnosed with diabetes, with similar rates between males (5.8%) and females (4.9%). The prevalence of diabetes has been steadily rising, particularly with age, reaching 18.7% among individuals aged 75 and older. Type 2 diabetes, which accounts for 87.6% of cases, is the most common form. Factors such as being born overseas, living in disadvantaged areas, and having a disability are linked to higher diabetes rates. As a result, the increasing prevalence of diabetes is expected to drive the growth of the blood glucose monitoring systems market.
Leading companies in the glucose monitoring systems market are focused on advancing technologies such as hybrid closed-loop systems and smartphone applications for real-time data access and management. Hybrid closed-loop systems automate insulin delivery based on real-time glucose readings, enhancing blood sugar control for individuals with diabetes. For instance, in February 2024, DexCom Inc., a US-based manufacturer, introduced Dexcom ONE+ in multiple European countries. This system integrates advanced sensor technology and user-friendly features, including a water-resistant sensor, a transmitter for continuous glucose monitoring, and a smartphone-compatible app. Dexcom ONE+ allows real-time monitoring of blood glucose levels by users and up to ten additional individuals, facilitating shared monitoring.
In September 2023, Abbott Laboratories expanded its diabetes management portfolio by acquiring Bigfoot Biomedical Inc., a US-based company specializing in diabetes management technology. This strategic move strengthens Abbott’s capabilities in glucose monitoring and insulin management solutions for diabetic patients.
Major companies operating in the blood glucose monitoring systems market are F. Hoffmann-La Roche Ltd., Medtronic plc, Dexcom Inc., SD Biosensor Co. Ltd., Arkray Inc., Abbott Laboratories, Ypsomed Holding AG, LifeScan IP Holdings LLC, Ascensia Diabetes Care Holdings AG, TaiDoc Technology Corporation, Nemaura Medical Inc., Bionime GmbH, Acon Laboratories Inc., Rossmax International Ltd, AgaMatrix Inc., A. Menarini Diagnostics S.r.l., Medisana GmbH, Intuity Medical Inc., GlucoTrack Ltd., Sinocare Inc., Omron Healthcare Co Ltd, Trividia Health Inc.
North America was the largest region in the blood glucose monitoring systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood glucose monitoring systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood glucose monitoring systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the blood glucose monitoring systems market by increasing the cost of electronic sensors, semiconductor chips, batteries, plastics, and sterile consumables sourced through global supply chains, leading to higher device manufacturing and distribution costs. The impact is most visible in continuous glucose monitoring systems, self-monitoring blood glucose meters, and disposable test strip segments produced in Asia-Pacific and European manufacturing hubs dependent on imported raw materials and precision components. Retail and institutional buyers are experiencing price pressures and extended procurement cycles as tariff-related costs cascade through distributors and healthcare providers. Nonetheless, tariffs are also encouraging localized component sourcing, regional device assembly, and domestic innovation activities, which may strengthen supply resilience and support long-term market competitiveness.
The blood glucose monitoring systems market research report is one of a series of new reports that provides blood glucose monitoring systems market statistics, including blood glucose monitoring systems industry global market size, regional shares, competitors with a blood glucose monitoring systems market share, detailed blood glucose monitoring systems market segments, market trends and opportunities, and any further data you may need to thrive in the blood glucose monitoring systems industry. This blood glucose monitoring systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A blood glucose monitoring system is a medical device designed to measure and show the concentration of glucose in the blood. It typically includes a compact, portable meter and a test strip where a drop of blood from a fingertip is applied. This system plays a crucial role in diabetes management by enabling individuals to monitor and regulate their blood sugar levels.
There are two main types of blood glucose monitoring systems non-invasive and invasive. Non-invasive systems do not require drawing blood and include devices such as continuous glucose monitoring systems and self-monitoring blood glucose systems for fingertip and alternative site testing. These systems are sold through institutional and retail channels, serving applications in type 2 diabetes, type 1 diabetes, and gestational diabetes.
The blood glucose monitoring systems market consists of sales of blood glucose meters, test strips, lancets, and lancing devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Blood Glucose Monitoring Systems Market Characteristics
3. Blood Glucose Monitoring Systems Market Supply Chain Analysis
4. Global Blood Glucose Monitoring Systems Market Trends and Strategies
5. Blood Glucose Monitoring Systems Market Analysis of End Use Industries
7. Global Blood Glucose Monitoring Systems Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Blood Glucose Monitoring Systems Total Addressable Market (TAM) Analysis for the Market
9. Blood Glucose Monitoring Systems Market Segmentation
10. Blood Glucose Monitoring Systems Market Regional and Country Analysis
11. Asia-Pacific Blood Glucose Monitoring Systems Market
12. China Blood Glucose Monitoring Systems Market
13. India Blood Glucose Monitoring Systems Market
14. Japan Blood Glucose Monitoring Systems Market
15. Australia Blood Glucose Monitoring Systems Market
16. Indonesia Blood Glucose Monitoring Systems Market
17. South Korea Blood Glucose Monitoring Systems Market
18. Taiwan Blood Glucose Monitoring Systems Market
19. South East Asia Blood Glucose Monitoring Systems Market
20. Western Europe Blood Glucose Monitoring Systems Market
21. UK Blood Glucose Monitoring Systems Market
22. Germany Blood Glucose Monitoring Systems Market
23. France Blood Glucose Monitoring Systems Market
24. Italy Blood Glucose Monitoring Systems Market
25. Spain Blood Glucose Monitoring Systems Market
26. Eastern Europe Blood Glucose Monitoring Systems Market
27. Russia Blood Glucose Monitoring Systems Market
28. North America Blood Glucose Monitoring Systems Market
29. USA Blood Glucose Monitoring Systems Market
30. Canada Blood Glucose Monitoring Systems Market
31. South America Blood Glucose Monitoring Systems Market
32. Brazil Blood Glucose Monitoring Systems Market
33. Middle East Blood Glucose Monitoring Systems Market
34. Africa Blood Glucose Monitoring Systems Market
36. Blood Glucose Monitoring Systems Market Competitive Landscape and Company Profiles
37. Blood Glucose Monitoring Systems Market Other Major and Innovative Companies
40. Blood Glucose Monitoring Systems Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Blood Glucose Monitoring Systems Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses blood glucose monitoring systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for blood glucose monitoring systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood glucose monitoring systems market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Non-Invasive; Invasive2) By Device Type: Continuous Glucose Monitoring Systems; Self-Monitoring Blood Glucose Systems
3) By Testing Site: Fingertip Testing; Alternate Site Testing
4) By Distribution Channel: Institutional Sales; Retail Sales
5) By Application: Type 2 Diabetes; Type 1 Diabetes; Gestational Diabetes
Subsegments:
1) By Non-Invasive: Optical Sensors; Ultrasound-Based Sensors; Bioimpedance-Based Sensors; Electromagnetic Sensors; Tear Or Saliva-Based Sensors2) By Invasive: Continuous Glucose Monitoring (CGM) Systems; Self-Monitoring Blood Glucose (SMBG) Systems; Implantable Glucose Monitoring Devices; Flash Glucose Monitoring Systems
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Medtronic plc; Dexcom Inc.; SD Biosensor Co. Ltd.; Arkray Inc.; Abbott Laboratories; Ypsomed Holding AG; LifeScan IP Holdings LLC; Ascensia Diabetes Care Holdings AG; TaiDoc Technology Corporation; Nemaura Medical Inc.; Bionime GmbH; Acon Laboratories Inc.; Rossmax International Ltd; AgaMatrix Inc.; A. Menarini Diagnostics S.r.l.; Medisana GmbH; Intuity Medical Inc.; GlucoTrack Ltd.; Sinocare Inc.; Omron Healthcare Co Ltd; Trividia Health Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Blood Glucose Monitoring Systems market report include:- F. Hoffmann-La Roche Ltd.
- Medtronic plc
- Dexcom Inc.
- SD Biosensor Co. Ltd.
- Arkray Inc.
- Abbott Laboratories
- Ypsomed Holding AG
- LifeScan IP Holdings LLC
- Ascensia Diabetes Care Holdings AG
- TaiDoc Technology Corporation
- Nemaura Medical Inc.
- Bionime GmbH
- Acon Laboratories Inc.
- Rossmax International Ltd
- AgaMatrix Inc.
- A. Menarini Diagnostics S.r.l.
- Medisana GmbH
- Intuity Medical Inc.
- GlucoTrack Ltd.
- Sinocare Inc.
- Omron Healthcare Co Ltd
- Trividia Health Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 19 Billion |
| Forecasted Market Value ( USD | $ 24.68 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
